Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gemcitabine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with gemcitabine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(gemcitabine)		Trials
(gemcitabine)		Recent Studies (post-2010) (gemcitabine)
9,15618755212,5233,2086,923

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)gemcitabine (IC50)
Chain A, DEOXYNUCLEOSIDE KINASEDrosophila melanogaster (fruit fly)0.76
Equilibrative nucleoside transporter 1Homo sapiens (human)0.19

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Awasthi, K; Chen, Y; Johnson, RM; Miller, KLR; Rapp, CM; Sahu, RP; Thyagarajan, A; Travers, JB1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gemcitabine

ArticleYear
Topical application of gemcitabine generates microvesicle particles in human and murine skin.
    BioFactors (Oxford, England), 2022, Volume: 48, Issue:6

    Topics: Animals; Gemcitabine; Humans; Mice; Platelet Activating Factor; Receptors, G-Protein-Coupled; Skin; Skin Neoplasms

2022